Citation: K. Jones et T. Bourne, The feasibility of a 'one stop' ultrasound-based clinic for the diagnosis and management of abnormal uterine bleeding, ULTRASOUN O, 17(6), 2001, pp. 517-521
Authors:
Krampl, E
Bourne, T
Hurlen-Solbakken, H
Istre, O
Citation: E. Krampl et al., Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding, ACT OBST SC, 80(7), 2001, pp. 616-622
Authors:
Strandell, A
Bourne, T
Bergh, C
Granberg, S
Thorburn, J
Hamberger, L
Citation: A. Strandell et al., A simplified ultrasound based infertility investigation protocol and its implications for patient management, J AS REPROD, 17(2), 2000, pp. 87-92
Authors:
Demyttenaere, K
Gheldof, M
Enzlin, P
Timmerman, D
Deprest, J
Bourne, T
Vergote, I
Citation: K. Demyttenaere et al., Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients, J PSYCH OBS, 21(4), 2000, pp. 225-233
Citation: K. Jermy et al., Uterine anomalies and failed surgical termination of pregnancy: the role of routine preoperative transvaginal sonography, ULTRASOUN O, 14(6), 1999, pp. 431-433
Authors:
Strandell, A
Bourne, T
Bergh, C
Granberg, S
Asztely, M
Thorburn, J
Citation: A. Strandell et al., The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients, ULTRASOUN O, 14(3), 1999, pp. 200-204
Authors:
Carmichael, PL
Sardar, S
Crooks, N
Neven, P
Van Hoof, I
Ugwumadu, A
Bourne, T
Tomas, E
Hellberg, P
Hewer, AJ
Phillips, DH
Citation: Pl. Carmichael et al., Lack of evidence from HPLC P-32-post-labelling for tamoxifen-DNA adducts in the human endometrium, CARCINOGENE, 20(2), 1999, pp. 339-342